Tarriff Scott Insider Trades

Insider Trading History

Track insider trading activity for Tarriff Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $212k 460,621 shares
Last Trade
Feb 28, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.3k 2,119 shares
$6.27
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $213k 462,740 shares
Last Trade
Feb 27, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.3k 3,154 shares
$6.44
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $214k 465,894 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.4k 12,950 shares
$6.44
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner
Holding Value $249k 541,125 shares
Last Trade
Jan 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.2k 4,322 shares
$5.13
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $251k 545,447 shares
Last Trade
Nov 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$148k 10,694 shares
$13.87
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $256k 556,141 shares
Last Trade
Nov 01, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$151k 10,925 shares
$13.82
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $261k 567,776 shares
Last Trade
Oct 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$155k 10,734 shares
$14.46
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $266k 577,800 shares
Last Trade
Oct 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$145k 9,511 shares
$15.23
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $270k 587,311 shares
Last Trade
May 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$300k 15,000 shares
$19.98
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $734k 1,595,134 shares
Last Trade
May 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$316k 15,000 shares
$21.07
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $746k 1,621,803 shares
Last Trade
May 12, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$304k 15,000 shares
$20.27
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $747k 1,624,934 shares
Last Trade
May 11, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$311k 15,000 shares
$20.71
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $754k 1,639,934 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 70,900 shares
$27.81
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $722k 1,569,034 shares
Last Trade
Feb 28, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$87.2k 3,113 shares
$28.00
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
CEO
Holding Value $723k 1,572,147 shares
Last Trade
Jan 23, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$126k 3,732 shares
$33.64
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
CEO
Holding Value $725k 1,575,879 shares
Last Trade
Jan 05, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$112k 3,827 shares
$29.26
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $727k 1,579,706 shares
Last Trade
Feb 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.65M 34,800 shares
$47.39
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $711k 1,544,906 shares
Last Trade
Apr 01, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$682k 16,278 shares
$41.87
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $718k 1,561,184 shares
Last Trade
Apr 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.31M 31,201 shares
$41.87
$0.46
Eagle Pharmaceuticals
Eagle Pharmaceuticals EGRX
10% owner, CEO
Holding Value $0 0 shares
Last Trade
Apr 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.31M 31,201 shares
$41.87
$0.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up